Literature DB >> 25546801

Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.

S von Gunten1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546801      PMCID： PMC4285530          DOI： 10.1111/cei.12550

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  9 in total

Review 1.  Cell death modulation by intravenous immunoglobulin.

Authors:  Stephan von Gunten; Hans-Uwe Simon
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

2.  Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.

Authors:  Camilla Jandus; Kayluz Frias Boligan; Obinna Chijioke; He Liu; Meike Dahlhaus; Thomas Démoulins; Christoph Schneider; Marc Wehrli; Robert E Hunger; Gabriela M Baerlocher; Hans-Uwe Simon; Pedro Romero; Christian Münz; Stephan von Gunten
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 3.  Intravenous immune globulin in autoimmune and inflammatory diseases.

Authors:  Erwin W Gelfand
Journal:  N Engl J Med       Date:  2012-11-22       Impact factor: 91.245

4.  IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.

Authors:  Stephan von Gunten; Yehuda Shoenfeld; Miri Blank; Donald R Branch; Tchavdar Vassilev; Fabian Käsermann; Jagadeesh Bayry; Srini Kaveri; Hans-Uwe Simon
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

Review 5.  Carbohydrates as future anti-adhesion drugs for infectious diseases.

Authors:  Nathan Sharon
Journal:  Biochim Biophys Acta       Date:  2006-01-18

6.  Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations.

Authors:  Stephan von Gunten; Alexander Schaub; Monique Vogel; Beda M Stadler; Sylvia Miescher; Hans-Uwe Simon
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

7.  Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.

Authors:  A Schaub; S von Gunten; M Vogel; S Wymann; M Rüegsegger; B M Stadler; M Spycher; H-U Simon; S Miescher
Journal:  Allergy       Date:  2011-03-09       Impact factor: 13.146

8.  Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.

Authors:  Stephan von Gunten; Monique Vogel; Alexander Schaub; Beda M Stadler; Sylvia Miescher; Paul R Crocker; Hans-Uwe Simon
Journal:  J Allergy Clin Immunol       Date:  2007-03-02       Impact factor: 10.793

9.  Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass.

Authors:  Stephan von Gunten; David F Smith; Richard D Cummings; Stefan Riedel; Sylvia Miescher; Alexander Schaub; Robert G Hamilton; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-05-13       Impact factor: 10.793
  9 in total
  1 in total

1.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.